Weil Company Inc. Invests $289,000 in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Weil Company Inc. acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 495 shares of the healthcare conglomerate’s stock, valued at approximately $289,000.

A number of other hedge funds also recently made changes to their positions in UNH. Delta Financial Advisors LLC raised its holdings in shares of UnitedHealth Group by 4.3% during the 3rd quarter. Delta Financial Advisors LLC now owns 3,783 shares of the healthcare conglomerate’s stock worth $2,212,000 after acquiring an additional 157 shares in the last quarter. Addison Advisors LLC raised its stake in UnitedHealth Group by 12.9% during the third quarter. Addison Advisors LLC now owns 480 shares of the healthcare conglomerate’s stock valued at $281,000 after purchasing an additional 55 shares in the last quarter. GDS Wealth Management increased its holdings in shares of UnitedHealth Group by 8.9% in the 3rd quarter. GDS Wealth Management now owns 21,539 shares of the healthcare conglomerate’s stock worth $12,593,000 after buying an additional 1,761 shares during the last quarter. Catalytic Wealth RIA LLC lifted its holdings in shares of UnitedHealth Group by 8.8% in the 3rd quarter. Catalytic Wealth RIA LLC now owns 9,959 shares of the healthcare conglomerate’s stock valued at $5,823,000 after acquiring an additional 807 shares during the last quarter. Finally, Proffitt & Goodson Inc. raised its position in UnitedHealth Group by 7.1% during the third quarter. Proffitt & Goodson Inc. now owns 1,624 shares of the healthcare conglomerate’s stock valued at $950,000 after purchasing an additional 107 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.3 %

Shares of NYSE UNH opened at $617.50 on Monday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $619.80. The stock’s fifty day simple moving average is $581.93 and its two-hundred day simple moving average is $545.85. The stock has a market capitalization of $568.27 billion, a PE ratio of 40.12, a price-to-earnings-growth ratio of 1.81 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the business earned $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Truist Financial restated a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Finally, Argus increased their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $615.53.

Read Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).